What you need to know about Corbevax the new patent free COVID vaccine
Corbevax was developed by the Texas Children’s Hospital’s Centre for vaccination research and Baylor College of Medicine in Houston, Texas, of USA. In India, this vaccine has been licensed to Biological E Limited for development and production. But what is a patent-free vaccine?
A patent-free vaccine means that the production and development of this vaccine does not require manufacturers to pay a hefty patent fee to the original developers, which in turn keeps the cost of the vaccine down, making it more affordable for people in all sections of society.
On average, currently, two doses of Corbevax can cost around $5, which translates to around 400 Rupees. If you were to buy and get any other vaccine available in India, it would cost you over Rs 1,000 even for a single dose in some cases. So, the low manufacturing and selling cost of Corbevax can be helpful in reducing the vaccination availability gap between the rich and poor sections of society.
Corbevax has many more great features and benefits that makes it a great vaccine in the world’s fight against COVID-19, so let’s take a detailed look at Corbevax and why it might be the key to ending the pandemic in the future.
How Does The Corbevax Vaccine Work?
The Corbevax vaccine is a protein subunit vaccine that uses a spike protein from the SARS CoV 2 virus, which can not harm you in any way. It is used to trigger an immune response in your body that will help you protect yourself against the virus. Corbevax is very safe, and like other vaccines, it also requires two doses to complete the vaccination process.
Why Is Corbevax Important?
Corbevax was developed by scientists that had previously created a vaccine for the SARS virus. When the COVID-19 pandemic struck with the SARS CoV 2 virus, these scientists were able to easily alter their vaccine to make it into a COVID-19 vaccine without much funding. They intentionally chose to use the protein subunit method to create the vaccine because it is easy to manufacture this vaccine, and it is easy to scale up the production of this vaccine as well at a low cost.
This is why Corbevax is important. It uses technology that supports easy scaling up to make sure that the vaccine can be produced easily and in large numbers to meet the needs of the huge population around the world. The patent-free vaccine also makes the cost of production and selling this vaccine quite low in comparison to other vaccines available in the market.
Did you know that the overall cost of production or the budget for the production of the major vaccines available in the market today, such as Covishield, crossed billions of dollars of development that were offered by governments and huge private companies around the world. Corbevax was developed on a budget of 7 million dollars, most of which came from private benefactors, the largest being a 1 million dollar donation grant from Tito’s Vodka. To make a fully functioning vaccine that has an efficacy rate of over 90% in protection against COVID-19, it sure is a gamechanger in the world of COVID-19 vaccines and in our fight against COVID.
Final Thoughts
Currently, Corbevax has been cleared for emergency use in India by the DGCI. It is also cleared for emergency use by the WHO. Vaccines such as Corbevax, when cleared for public vaccination in India, can be a real gamechanger in providing quality vaccination at very affordable prices to a major section of society. So, if you want to learn more about Corbevax its current status of approval from the government, be sure to visit, Medipulse hospital or go to their official website for more information on their COVID vaccination program.